- ICH GCP
- US Clinical Trials Registry
- Researchers
- France
- Pancreatic Neoplasms
Medical specialists from France tagged as investigators in clinical trials studying Pancreatic Neoplasms
Total 193 results
-
Khadija KALAISeen in:
- Amiens, Clinique privée de l'Europe
Trials:- NCT03693677 (Principal Investigator)
Conditions: -
Kheir Eddine BENMAMMARSeen in:
- Le Puy-en-Velay, Hôpital Emile Roux
Trials:- NCT03693677 (Principal Investigator)
Conditions: -
Laétitia DAHAN, MDSeen in:
- Marseille, APHM - CHU La Timone
- Marseille, Hopital de la Timone
- Marseille, Hôpital La Timone
Trials:- NCT03678883 (Principal Investigator)
- NCT04749108 (Principal Investigator)
- NCT04730544 (Principal Investigator)
- NCT05615818 (Principal Investigator)
Conditions:- Sarcoma;
- Cancer;
- Breast Neoplasms;
- Neoplasm Metastasis;
- Pancreatic Neoplasms;
- Pancreatic Cancer;
- Pancreatic Adenocarcinoma;
- Bone Cancer;
- Malignant Glioma;
- Bone Metastases;
- Pancreas Cancer;
- Renal Cancer;
- Refractory Non-Hodgkin Lymphoma;
- Bone Neoplasm;
- Neoplasm, Breast;
- Refractory Cancer;
- Refractory Neoplasm;
- Resistant Cancer;
- Neoplasm of Bone;
- Neoplasm of Lung;
- Neoplasms,Colorectal;
- Neoplasms Pancreatic;
- Malignancies;
- Malignancies Multiple;
- Acute T Cell Leukemia Lymphoma;
- Rectal Carcinoma;
- Locally Advanced Malignant Neoplasm;
- Colorectal Cancer Metastatic;
- MSI-H Colorectal Cancer;
- Biliary Tract Neoplasms
-
Laurence THOMAS MARQUESSeen in:
- Meaux, CH
Trials:- NCT03693677 (Sub-Investigator)
Conditions: -
Laurent ALCARAZSeen in:
- Nîmes, Centre Médical ONCOGARD
Trials:- NCT03693677 (Principal Investigator)
Conditions: -
Laurent MOSSERSeen in:
- Rodez, CH
- Rodez, CH Jacques Puel
Trials:- NCT02355379 (Principal Investigator)
- NCT03693677 (Principal Investigator)
Conditions: -
Léa CLAVELSeen in:
- Lyon, Clinique Privée Jean Mermoz
- Saint-Priest-en-Jarez, Chu - Hopital Nord Chu Saint Etienne
Trials:- NCT03693677 (Sub-Investigator)
- NCT02885753 (Sub-Investigator)
Conditions: -
Lea SABAN-ROCHE, MDSeen in:
- Saint-Priest-en-Jarez, Institut Cancérologique Lucien Newirth (ICLN)
Trials:- NCT04374175 (Principal Investigator)
Conditions: -
LEBTAHI Rachida, PrSeen in:
- Clichy, Médecine nucléaire et Biophysique - Beaujon
Trials:- NCT06256705 (Principal Investigator)
Conditions: -
Leila BENGRINE LEFEVRESeen in:
- Dijon, Centre GF Leclerc
Trials:- NCT03693677 (Principal Investigator)
Conditions: -
Louis de MestierSeen in:
- Clichy, CHU Beaujon, APHP.Nord - Université Paris Cité
- Clichy, Pancréatologie et Oncologie Digestive - Beaujon
Trials:- NCT05477576 (Principal Investigator)
- NCT06256705 (Principal Investigator)
-
Marc PRIETOSeen in:
- Meaux, CH
Trials:- NCT03693677 (Sub-Investigator)
Conditions: -
Marie-Line GARCIA LARNICOL, MDSeen in:
- Paris, Hôpital Saint Antoine
Trials:- NCT02184663 (Principal Investigator)
-
Marine GILABERTSeen in:
- Marseille, Institut Paoli Calmettes
Trials:- NCT03693677 (Principal Investigator)
Conditions: -
Marion BOLLIETSeen in:
- Colmar, Hôpitaux civils de Colmar
Trials:- NCT03693677 (Sub-Investigator)
Conditions: -
Marjorie FAURESeen in:
- Marseille, Institut Paoli Calmettes
Trials:- NCT03693677 (Sub-Investigator)
Conditions: -
May MABROSeen in:
- Suresnes, CH Foch
- Suresnes, Hôpital Foch
Trials:- NCT03693677 (Principal Investigator)
- NCT02184663 (Principal Investigator)
- NCT01910610 (Principal Investigator)
-
Meher Benabdelghani, MDSeen in:
- Strasbourg, Centre PAUL STRAUSS
Trials:- NCT03400072 (Principal Investigator)
Conditions: -
Mélanie HASSINESeen in:
- Rouen, CHU Charles Nicolle
Trials:- NCT03693677 (Sub-Investigator)
Conditions: -
Michael Duruisseaux, MDSeen in:
- Bron, CHU de Lyon - Louis Pradel Hospital
- Bron, Hôpital Louis Pradel - Department of Pneumology
- Lyon, Hospital Louis Pradel, FR
Trials:- NCT02912949 (Principal Investigator)
- NCT04868877 (Principal Investigator)
- NCT04605146 (Principal Investigator)
-
Mohamed BOUCHAHDA, DrSeen in:
- IDF, Évry, Clinique Du Mousseau
Trials:- NCT04263948 (Principal Investigator)
Conditions: -
Nathalie BAIZESeen in:
- Angers, CHU - Hôtel Dieu
- Angers, CHU Hotel Dieu
Trials:- NCT03693677 (Sub-Investigator)
- NCT02885753 (Sub-Investigator)
Conditions: -
Nicolas BARRIERESeen in:
- Marseille, Hôpital Européen
- Marseille, PRIVE - Hôpital Européen
Trials:- NCT03693677 (Sub-Investigator)
- NCT02885753 (Sub-Investigator)
Conditions: -
Nicolas WILLIET, MDSeen in:
- Saint-Étienne, Chu Saint-Etienne
Trials:- NCT04374175 (Principal Investigator)
Conditions: -
Nils STEUERSeen in:
- Bobigny, CHU Avicenne
Trials:- NCT03693677 (Sub-Investigator)
Conditions: -
Olivier Bouché, MD PhDSeen in:
- Reims, CHU de Reims
Trials:- NCT03400072 (Principal Investigator)
Conditions: -
Olivier Riou, MDSeen in:
- Montpellier, Institut régional du Cancer de Montpellier
Trials:- NCT04698915 (Principal Investigator)
-
Pascal ARTRUSeen in:
- Lyon, Clinique Privée Jean Mermoz
Trials:- NCT03693677 (Sub-Investigator)
Conditions:
Clinical Trials on Pancreatic Neoplasms
-
City of Hope Medical CenterRecruitingPancreatic Neoplasms | Pancreatic Cancer | Pancreatic Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | Pancreatic Cancer Resectable | Pancreatic Carcinoma | Pancreatic Cancer Non-resectable | Pancreatic Cancer Stage III | Pancreatic Cancer Stage | Pancreatic Cancer Stage II | Pancreatic Cancer, Adult | Pancreatic... and other conditionsKorea, Republic of, United States, Japan
-
Memorial Sloan Kettering Cancer CenterRecruitingPancreatic Cancer | Pancreatic Cancer Metastatic | Pancreatic Cancer Stage IV | Metastatic Pancreatic Carcinoma | Metastatic Pancreatic Adenocarcinoma | Pancreatic Carcinoma | Metastatic Pancreatic Cancer | Pancreatic Cancer Non-resectable | Metastatic Pancreatic Ductal Adenocarcinoma | Pancreatic Carcinoma... and other conditionsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CelgeneWithdrawnPancreatic Ductal Adenocarcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
University of UtahNovartis PharmaceuticalsRecruitingMetastatic Pancreatic Carcinoma | Unresectable Pancreatic Carcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage II Pancreatic CancerUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedPancreatic Adenocarcinoma | Resectable Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer | Poorly Differentiated Malignant Neoplasm | Undifferentiated Pancreatic CarcinomaUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science University; Celgene CorporationCompletedPancreatic Adenocarcinoma | Resectable Pancreatic CarcinomaUnited States
-
Laser Tissue Welding, Inc.National Cancer Institute (NCI); CHI St. Luke's Health, TexasCompletedPancreatic Neoplasms | Pancreatic Adenocarcinoma | Pancreatic Cyst | Pancreatic Neuroendocrine Tumor | Pancreatic Polypeptide Tumor | Pancreatic Pseudocyst | Pancreatic Glucagonoma | Pancreas Injury | Pancreatic Cystadenoma | Pancreatic Tumor, Benign | Pancreas; Insulinoma | Pancreatic Teratoma | Pancreatic Vipoma and other conditionsUnited States
-
The First Affiliated Hospital with Nanjing Medical...RecruitingLocally Advanced Pancreatic Adenocarcinoma | Metastatic Pancreatic Cancer | Pancreatic NeoplasmChina
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedPancreatic Adenocarcinoma | Recurrent Pancreatic Carcinoma | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnStage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer